CA9 and hepatocellular carcinoma: Additionally, hepatocellular carcinoma (HCC) is characterized by the up-regulated expression of carbonic anhydrase IX (CA-IX), an enzyme implicated in pH reduction, and in recent years, carbonic anhydrase inhibitors have emerged as potential agents for hypoxic tumor therapy and imaging [107].